GPR78
gene geneOn this page
Summary
GPR78 (G protein-coupled receptor 78, HGNC:4528) is a protein-coding gene on chromosome 4p16.1, encoding G-protein coupled receptor 78 (Q96P69). Orphan receptor.
The protein encoded by this gene belongs to the G protein-coupled receptor family, which contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. This is an orphan receptor, which displays significant level of constitutive activity. Association analysis shows preliminary evidence for the involvement of this gene in susceptibility to bipolar affective disorder and schizophrenia. Alternatively spliced transcript variants have been found for this gene.
Source: NCBI Gene 27201 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 103 total
- Druggable target: yes
- MANE Select transcript:
NM_080819
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4528 |
| Approved symbol | GPR78 |
| Name | G protein-coupled receptor 78 |
| Location | 4p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000155269 |
| Ensembl biotype | protein_coding |
| OMIM | 606921 |
| Entrez | 27201 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding_CDS_not_defined, 1 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000382487, ENST00000503448, ENST00000503981, ENST00000504255, ENST00000509216, ENST00000513120, ENST00000514302
RefSeq mRNA: 1 — MANE Select: NM_080819
NM_080819
CCDS: CCDS3403
Canonical transcript exons
ENST00000382487 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001492278 | 8580392 | 8581650 |
| ENSE00002026341 | 8587054 | 8590023 |
| ENSE00003577738 | 8582531 | 8582644 |
Expression profiles
Bgee: expression breadth broad, 87 present calls, max score 85.15.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2402 / max 79.6596, expressed in 42 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46891 | 0.0572 | 14 |
| 46895 | 0.0559 | 17 |
| 46897 | 0.0531 | 10 |
| 46894 | 0.0478 | 9 |
| 46896 | 0.0262 | 9 |
Top tissues by expression
205 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 85.15 | gold quality |
| esophagus mucosa | UBERON:0002469 | 81.24 | gold quality |
| left ovary | UBERON:0002119 | 79.95 | gold quality |
| right ovary | UBERON:0002118 | 75.47 | gold quality |
| ovary | UBERON:0000992 | 72.61 | gold quality |
| vagina | UBERON:0000996 | 66.37 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.00 | gold quality |
| ectocervix | UBERON:0012249 | 62.88 | gold quality |
| uterine cervix | UBERON:0000002 | 60.84 | gold quality |
| esophagus | UBERON:0001043 | 60.15 | gold quality |
| right uterine tube | UBERON:0001302 | 59.45 | gold quality |
| endocervix | UBERON:0000458 | 58.57 | gold quality |
| female reproductive system | UBERON:0000474 | 57.31 | gold quality |
| skin of hip | UBERON:0001554 | 56.81 | gold quality |
| gall bladder | UBERON:0002110 | 55.57 | gold quality |
| prefrontal cortex | UBERON:0000451 | 55.25 | gold quality |
| decidua | UBERON:0002450 | 55.16 | gold quality |
| placenta | UBERON:0001987 | 52.14 | gold quality |
| left uterine tube | UBERON:0001303 | 50.99 | gold quality |
| upper leg skin | UBERON:0004262 | 50.64 | silver quality |
| body of uterus | UBERON:0009853 | 50.11 | gold quality |
| fallopian tube | UBERON:0003889 | 49.82 | gold quality |
| sural nerve | UBERON:0015488 | 49.67 | gold quality |
| urinary bladder | UBERON:0001255 | 49.62 | gold quality |
| colonic epithelium | UBERON:0000397 | 49.38 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 49.16 | gold quality |
| medial globus pallidus | UBERON:0002477 | 48.97 | gold quality |
| frontal cortex | UBERON:0001870 | 48.26 | gold quality |
| uterus | UBERON:0000995 | 48.21 | gold quality |
| neocortex | UBERON:0001950 | 47.43 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6701 | yes | 65.41 |
| E-MTAB-6678 | yes | 6.35 |
| E-ANND-3 | yes | 3.38 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
74 targeting GPR78, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-329-3P | 99.91 | 66.56 | 1234 |
| HSA-MIR-362-3P | 99.91 | 66.38 | 1267 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
Literature-anchored findings (GeneRIF, showing 6)
- Two haplotypes remained significant in both the female bipolar affective disorder individuals and in the full sample of affected female individuals. Results provide preliminary evidence for involvement of GPR78 in susceptibility to BPAD and SCZ. (PMID:16389273)
- Knockdown of GPR78 in lung cancer cells suppressed cell migration and GPR78 modulated the formation of actin stress fibers in A549 cells, in a RhoA- and Rac1-dependent manner. (PMID:27697106)
- We reveal distinct binding affinities between the binary and ternary complexes thus formed, that suggest a preference for the PERK signaling branch under stress, and a predilection for the GRP78-UPR sensor complex formation upon stressor removal. These results imply a gated UPR mechanism that tunes the overall cellular behavior to the accumulation of unfolded proteins. (PMID:28416388)
- rs7676745, located near GPR78, associates with lower odds of surviving to the 90th percentile age. [Meta-analysis] (PMID:31413261)
- Association of G protein-coupled receptor 78 with salivary dysfunction in male Sjogren’s patients. (PMID:36652502)
- COLEC10 Induces Endoplasmic Reticulum Stress by Occupying GRP78 and Inhibits Hepatocellular Carcinoma. (PMID:36925047)
Cross-species orthologs
0 orthologs
Paralogs (3): GPR63 (ENSG00000112218), GPR45 (ENSG00000135973), GPR26 (ENSG00000154478)
Protein
Protein identifiers
G-protein coupled receptor 78 — Q96P69 (reviewed: Q96P69)
All UniProt accessions (3): Q96P69, B2R7M4, D6RB95
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor. Displays a significant level of constitutive activity. Its effect is mediated by G(s)-alpha protein that stimulate adenylate cyclase, resulting in an elevation of intracellular cAMP.
Subcellular location. Cell membrane.
Tissue specificity. High level of expression in placenta. Expressed throughout the brain at low level. No expression detected in skeletal muscle, lung, heart, liver, pancreas, or kidney.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_543009* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR049579 | GPR26/78-like | Family |
| IPR051880 | GPC_Orphan_Receptors | Family |
Pfam: PF00001
UniProt features (25 total): topological domain 8, transmembrane region 7, sequence variant 3, sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1, disulfide bond 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96P69-F1 | 84.35 | 0.60 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 79–156
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 236 | no effect on constitutive activity. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, chr4p16, HAMAI_APOPTOSIS_VIA_TRAIL_DN, GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, LMTK3_TARGET_GENES, NFKBIA_TARGET_GENES, PBXIP1_TARGET_GENES, ZNF512_TARGET_GENES, ZNF512B_TARGET_GENES, ZNF7_TARGET_GENES, MIR4531
GO Biological Process (3): adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1 |
| adenylate cyclase activator activity | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
494 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR78 | LPAR1 | P78351 | 810 |
| GPR78 | ATF6 | P18850 | 735 |
| GPR78 | ERN1 | O75460 | 686 |
| GPR78 | HSPA5 | P11021 | 669 |
| GPR78 | DNAJC1 | Q96KC8 | 559 |
| GPR78 | DDIT3 | P35638 | 477 |
| GPR78 | XBP1 | P17861 | 475 |
| GPR78 | CRIPTO | P13385 | 430 |
| GPR78 | EIF2AK3 | Q9NZJ5 | 404 |
| GPR78 | HSP90B1 | P14625 | 378 |
| GPR78 | GPR61 | Q9BZJ8 | 357 |
| GPR78 | RDH16 | O75452 | 353 |
| GPR78 | THRSP | Q92748 | 349 |
| GPR78 | FDPS | P14324 | 349 |
| GPR78 | ELAVL1 | Q15717 | 349 |
IntAct
0 interactions, top by confidence:
BioGRID (1): APP (Reconstituted Complex)
ESM2 similar proteins: A0A6I8PUB9, O00155, O00270, O14842, O14843, O15529, O43603, O46685, O60755, O88626, O88634, O88853, O88854, O88855, P0C5I1, P46092, P46093, P50132, Q149R9, Q15722, Q15743, Q1JQB3, Q3T181, Q3UFD7, Q3ZC80, Q4KLH9, Q6XKD3, Q76JU8, Q76JU9, Q76JV1, Q86VZ1, Q8BUD0, Q8BYC4, Q8HYC3, Q8K3T4, Q8TDS5, Q8TDU9, Q920E0, Q924U0, Q96G91
Diamond homologs: A6NM03, P16395, P21451, P30729, P48302, P51436, Q59E83, Q8BZA7, Q8NDV2, Q8NGQ2, Q93126, Q96P69, Q9H205, Q9N0W7, Q9QXI3, B2RPY5, O62709, P20905, P21917, P24530, P28088, P35463, P56497, Q1JPS6, Q6TAC8, Q6TLJ0, Q6XL69, Q8NH40, A0A6I8PUB9, O77408
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
103 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 95 |
| Likely benign | 4 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2922 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:8581648:CAGGT:C | donor_loss | 1.0000 |
| 4:8581649:AGGTA:A | donor_loss | 1.0000 |
| 4:8582528:CA:C | acceptor_loss | 1.0000 |
| 4:8582529:A:AG | acceptor_gain | 1.0000 |
| 4:8582529:A:C | acceptor_loss | 1.0000 |
| 4:8582529:AGT:A | acceptor_gain | 1.0000 |
| 4:8582529:AGTGT:A | acceptor_gain | 1.0000 |
| 4:8582530:G:C | acceptor_loss | 1.0000 |
| 4:8582530:G:GA | acceptor_gain | 1.0000 |
| 4:8582530:GT:G | acceptor_gain | 1.0000 |
| 4:8582530:GTG:G | acceptor_gain | 1.0000 |
| 4:8582530:GTGT:G | acceptor_gain | 1.0000 |
| 4:8582530:GTGTG:G | acceptor_gain | 1.0000 |
| 4:8582585:G:GT | donor_gain | 1.0000 |
| 4:8582641:CCAG:C | donor_loss | 1.0000 |
| 4:8582643:AGGTG:A | donor_loss | 1.0000 |
| 4:8582644:GGTG:G | donor_loss | 1.0000 |
| 4:8582645:G:GC | donor_loss | 1.0000 |
| 4:8582646:T:A | donor_loss | 1.0000 |
| 4:8587052:AGGCT:A | acceptor_gain | 1.0000 |
| 4:8587053:GGCTG:G | acceptor_gain | 1.0000 |
| 4:8601495:GGG:G | donor_gain | 1.0000 |
| 4:8601496:GG:G | donor_gain | 1.0000 |
| 4:8601496:GGG:G | donor_gain | 1.0000 |
| 4:8601497:GG:G | donor_gain | 1.0000 |
| 4:8601497:GGTA:G | donor_loss | 1.0000 |
| 4:8601498:G:GG | donor_gain | 1.0000 |
| 4:8601498:G:T | donor_loss | 1.0000 |
| 4:8601499:T:G | donor_loss | 1.0000 |
| 4:8603975:GGA:G | acceptor_gain | 1.0000 |
AlphaMissense
2283 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:8587106:A:C | S279R | 0.981 |
| 4:8587108:C:A | S279R | 0.981 |
| 4:8587108:C:G | S279R | 0.981 |
| 4:8587124:A:C | S285R | 0.975 |
| 4:8587126:C:A | S285R | 0.975 |
| 4:8587126:C:G | S285R | 0.975 |
| 4:8581123:T:A | N47K | 0.974 |
| 4:8581123:T:G | N47K | 0.974 |
| 4:8582610:T:C | F250L | 0.969 |
| 4:8582612:C:A | F250L | 0.969 |
| 4:8582612:C:G | F250L | 0.969 |
| 4:8582629:C:G | P256R | 0.968 |
| 4:8581268:A:C | S96R | 0.967 |
| 4:8581270:C:A | S96R | 0.967 |
| 4:8581270:C:G | S96R | 0.967 |
| 4:8582629:C:A | P256Q | 0.965 |
| 4:8581496:T:C | F172L | 0.964 |
| 4:8581498:C:A | F172L | 0.964 |
| 4:8581498:C:G | F172L | 0.964 |
| 4:8581439:T:C | F153L | 0.961 |
| 4:8581441:C:A | F153L | 0.961 |
| 4:8581441:C:G | F153L | 0.961 |
| 4:8581487:T:C | F169L | 0.958 |
| 4:8581489:C:A | F169L | 0.958 |
| 4:8581489:C:G | F169L | 0.958 |
| 4:8587111:G:C | K280N | 0.958 |
| 4:8587111:G:T | K280N | 0.958 |
| 4:8581373:T:A | W131R | 0.954 |
| 4:8581373:T:C | W131R | 0.954 |
| 4:8581523:T:C | F181L | 0.954 |
dbSNP variants (sampled 300 via entrez): RS10000720 (4:8582368 C>A,G,T), RS1000297181 (4:8585203 C>T), RS10006769 (4:8584035 C>T), RS1000731675 (4:8580576 A>G), RS1000761743 (4:8580700 G>C), RS1000816513 (4:8589950 A>G,T), RS1000882171 (4:8586636 C>T), RS1001062120 (4:8579134 G>T), RS1001118890 (4:8587652 T>C), RS1001395009 (4:8583727 G>A), RS1001451292 (4:8580344 C>T), RS1001459938 (4:8582810 A>C,G), RS1001502080 (4:8580190 C>T), RS1001765588 (4:8583937 A>T), RS1001837269 (4:8580899 G>A,T)
Disease associations
OMIM: gene MIM:606921 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005754_2 | Systemic lupus erythematosus | 3.000000e-11 |
| GCST008163_138 | Height | 8.000000e-06 |
| GCST008600_2 | Longevity (age >90th survival percentile) | 2.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523908 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | decreases expression | 1 |
| terbufos | decreases methylation | 1 |
| MT19c compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Fonofos | decreases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Parathion | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883468 | Binding | PRESTO-Tango GPCRome screening (GPR78) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
2 cell lines: 1 spontaneously immortalized cell line, 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KX72 | PathHunter CHO-K1 GPR78 beta-arrestin | Spontaneously immortalized cell line | Female |
| CVCL_XP34 | HAP1 GPR78 (-) | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.